Chronic diarrhoea: Current concepts on mechanisms and management

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 2, 1996, Pages 157-167

  Farthing, Michael J G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Chronic diarrhoea; Management; Mechanisms; Treatment

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDIARRHEAL AGENT; OCTREOTIDE; OPIATE; ORAL REHYDRATION SOLUTION; SEROTONIN ANTAGONIST; SOMATOSTATIN DERIVATIVE; STOMACH SECRETION INHIBITOR;

BACTERIAL OVERGROWTH; CHRONIC DIARRHEA; FECES ANALYSIS; HUMAN; INTESTINE ABSORPTION; INTESTINE SECRETION; ORAL DRUG ADMINISTRATION; ORAL REHYDRATION THERAPY; PRIORITY JOURNAL; REVIEW;

EID: 0029926679     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199602000-00013     Document Type: Review

References (60)

1. World Health Organisation: Programme for control of diarrhoeal diseases: interim programme report 1990. Geneva: WHO:1990; 34-36.
2. Guandalini S: Overview of childhood acute diarrhoea in Europe: implications for oral rehydration therapy. Acta Paediatr Scand 1989, 364(suppl):5-12.
3. Farthing MJG: History and rationale of oral rehydration and recent developments in formulating an optimal solution. In Advances in Oral Rehydration. Drugs 1988, 36(Suppl 4):80-90.
4. Sturchler D: Parasitic diseases of the small intestinal tract. In Bailliere's Clinical Gastroenterology 1987, 1:397-424.
5. McGowan I, Weller I: AIDS and the gut. In Recent Advances in Gastroenterology S. Edited by Pounder RE. London: Churchill Livingstone; 1990:133-156.
6. Schiller LR, Hogan RB, Morawski SG, et al.: Studies of the prevalence and significance of radiolabelled bile acid malabsorption in a group of patients with idiopathic chronic diarrhea. Gastroenterology 1987, 92:151-160.
7. Nightingale JMD, Lennard-Jones JE, Walker ER, Farthing MJG: lejunal reflux in short bowel syndrome. Lancet 1990, 336:765-768.
8. Farthing MJG: Host-parasite interactions in human giardiasis. Quart J Med 1989, 70:191-204.
9. Salim AFM, Phillips AD, Farthing MJG: Pathogenesis of gut virus infection. Clin Gastroenterol 1990, 4:593-607.
10. Swinson CM, Levi AJ: Is coeliac disease underdiagnosed? Br Med J 1980, 2:1258-1260.
11. MacDonald TT, Spencer J: Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 1988, 167:1341-1349.
12. Farthing MJG: Immunopathology of giardiasis. Springer Semin Immunopathol 1990, 12:269-282.
13. Milla PJ: Congenital diarrhea. In Diarrhoeal Diseases. Edited by Field M. Elsevier Science Publishing Co Inc; 1991:373-396.
14. Spiller RC: Diarrhoea. In Gastrointestinal Transit: Pathophysiology and Pharmacology. Edited by Kamm MA, Lennard-Jones JE. Petersfield: Wrightson Biomedical Publishing Ltd; 1991:141-156.
15. Turnberg LA: Cellular basis of diarrhoea. J R Coll Phys Lond 1991, 25:53-62.
16. Madara JL, Patapoff TW, Gillece-Castro B, Colgan SP, Parkos CA, Delp C, et al.: 5′-Adenosine monophosphate is the neutrophil derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial monolayers. J Clin Invest 1993, 91:2320-2325.
17. Byars ME, Farraresi RW: Intestinal anaphylaxis in the rat as a model of food allergy. Clin Exp Immunol 1976, 24:352-356.
18. Gustowska L, Ruitenberg EJ, Elgersma A, Kociecka W: Increase of mast cells in the jejunum of patients infected with Trichinella spiralis. Int Arch Allerg Appl Immunol 1983, 71:304-308.
19. Crowe SC, Sestini P, Perdue MH: Allergic reaction of rat jejunal mucosa. Ion transport responses to luminal antigen and inflammatory mediators. Gastroenterology 1990, 99:74-82.
20. Farthing MJG: 5-hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists. Scand J Gastroenterol 1991, 26(suppl 188):92-100.
21. Field M, Rao MC, Change EB: Intestinal electrolyte transport and diarrhoeal disease. N Engl J Med 1989, 321:800-806, 879-883.
22. Fingl E: Laxatives and chathartics. In The Pharmacological Basis of Therapeutics. Edited by Gillman AG, Goodman LS. New York: Macmillan; 1980:1002.
23. Izzo AA, Gaginella TS, Mascolo N, Capasso F: Nitric oxide as a mediator of the laxative action of magnesium sulphate. Br J Pharmacol 1994, 113:228-232.
24. Casemore DP, Armstrong M, Sands RL: Laboratory diagnosis of cryptosporidiosis. J Clin Path 1985, 38:1337-1341.
25. Weber R, Bryan RT, Owen RL, Wilcox CM, Gorelkin L, Visvesvara GS: Improved light-microscopical detection of microsporidia spores in stool and duodenal aspirates. N Engl J Med 1992, 326:161-166.
26. Goka AKJ, Rolston DDK, Mathan VI, Farthing MJG: The relative merits of faecal and duodenal juice microscopy in the diagnosis of giardiasis. Trans R Soc Trop Med Hyg 1990, 84:66-67.
27. Char S, Farthing MJG: DNA probes for diagnosis of enteric infection. Gut 1991, 32:1-3.
28. Relman DA, Schmidt TM, MacDermott RP, Falkow S: Identification of the uncultured bacillus of Whipple's disease. N Engl J Med 1992, 327:293-301.
29. Lowsky R, Archer GL, Fyles G, Minden M, Curtis J, Messner H, et al.: Diagnosis of Whipple's disease by molecular analysis of peripheral blood. N Engl J Med 1994, 331:1343-1346.
30. Duncan A, Morris AJ, Cameron A, Stewart MJ, Brydon WG, Russell RI: Laxative induced diarrhoea - a neglected diagnosis. J R Soc Med 1992, 85:203-205.
31. Ewe K, Karbach U: Factitious diarrhoea. Clin Gastroenterol 1986, 15:723-740.
32. Topazian M, Binder HJ: Factitious diarrhea detected by measurement of stool osmolality. N Engl J Med 1994, 330:1418-1419.
33. Farthing MJG: Mycobacterial disease of the gut. In Modern Coloproctology. Edited by Phillips RSK, Northover JMA. London: Edward Arnold; 1993:174-189.
34. Arvind AS, Shetty N, Farthing MJG. Serodiagnosis of amoebiasis. Serodiagn Immunother 1988, 2:79-84.
35. Luk GD: Screening for steatorrhea. Gastroenterol 1979, 77:205-206.
36. McMillan SA, Haughton DJ, Biggart JD, Edgar JD, Porter KG, McNeill TA: Predictive value for coeliac disease of antibodies to gliadin, endomysium, and jejunum in patients attending for jejunal biopsy. BMJ 1991, 303:1163-1165.
37. Brocchi E, Corazza GR, Caletti G, Treggiari EA, Barbara L, Gasbarrini G: Endoscopic demonstration of loss of duodenal folds in the diagnosis of celiac disease. N Engl J Med 1988, 319:741-744.
38. Goka AKJ, Rolston DDK, Mathan VI, Farthing MJG: Diagnosis of strongyloides and hookworm infections: comparison of faecal and duodenal juice microscopy. Trans R Soc Trop Med Hyg 1990, 84:829-831.
39. Virgolini I, Raderer M, Kurtaran A, Angelberger P, Banyai S, Yang Q, et al.: Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumours. N Engl J Med 1994, 331:1116-1121.
40. 3] octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993, 20:716-731.
41. Bo-Linn GW, Vendrell DD, Lee E, Fordtran JS: An evaluation of the significance of microscopic colitis in patients with chronic diarrhea. J Clin Invest 1985, 75:1559-1569.
42. Giardiello FM, Bayless TM, Jessurun J, Hamilton SR, Yardley JH: Collagenous colitis: physiologic and histopathologic studies in seven patients. Ann Intern Med 1987, 106:46-49.
43. Rams H, Rogers AI, Ghandur-Mnaymneh L: Collagenous colitis. Ann Intern Med 1987, 106:108-113.
44. Corazza CR, Menozzi MG, Strocchi A, Rasciti L, Vaira D, Lecchini R, et al: The diagnosis of small bowel bacterial overgrowth. Gastroenterology 1990, 98:302-309.
45. Schiller LR, Hogan RB, Morawski SC, Santa Ana CA, Bern MJ, Norgaard RP, et al.: Studies of the prevalence and significance of radiolabelled bile acid malabsorption in a group of patients with idiopathic chronic diarrhea. Gastroenterology 1987, 92:151-160.
46. Schiller LR, Bilhartz LE, Santa Ana CA, Fordtran JS: Comparison of endogenous and radiolabeled bile acid excretion in patients with idiopathic chronic diarrhea. Gastroenterology 1990, 98:1036-1043.
47. Schiller LR: Anti-diarrhoeal pharmacology and therapeutics. Aliment Pharmacol Ther 1995; in press.
48. Pamukcu R, Chang EB: Alpha-2-adrenergic agonists as anti-diarrhoeal agents. A review of physiological and cellular mechanisms. In Textbook of Secretory Diarrhea. Edited by Lebenthal E, Duffey M. New York: Raven Press; 1990:383-393.
49. Baumer P, Danquechin-Dorval E, Bertrand J, Vetel JM, Schwartz JC, Lecomte JM: Effects of acetorphan, an encephalinase inhibitor, on experimental and acute diarrhoea. Gut 1992; 33:753-758.
50. Burroughs AK, McCormick PA: Somatostain and octreotide in gastroenterology. Aliment Pharmacol Ther 1991, 5:331-341.
51. Gorden P, Comi PJ, Maton PN: Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumours of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut. Ann Intern Med 1989, 110:35-50.
52. Harris AG: Octreotide in the treatment of disorders of the gastrointestinal system. Drugs 1992, in press.
53. Nightingale JMD, Walker ER, Burnham WR, Farthing MJG, Lennard-Jones JE: Octreotide (a somatostatin analogue) improves the quality of life in some patients with a short intestine. Aliment Pharmacol Ther 1989, 3:367-373.
54. Rodrigues CA, Lennard-Jones JE, Thompson DG, Farthing MJG: The effects of octreotide, soy polysaccharide, codeine and loperamide on nutrient, fluid and electrolyte absorption in the short-bowel syndrome. Aliment Pharmacol Ther 1989, 3:159-169.
55. Mourad FH, Gorard D, Thillainayagam AV, Colin-Jones D, Farthing MIG: Effective treatment of diabetic diarrhoea with somatostatin analogue, octreotide. Gut 1992, 33:1578-1580.
56. Fetrelli NJ: Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for treatment of chemotherapy-induced diarrhea in patients with colorectal cancer. Cancer 1993, 72:1543-1546.
57. O'Donnell LJD, Watson AJM, Cameron D, Farthing MJG: Effect of octreotide on mouth-to-caecum transit time in healthy subjects and in the irritable bowel syndrome. Aliment Pharmacol Ther 1990, 4:177-182.
58. Soudah HC, Hasler WL, Owyang C: Effect of otreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991, 325:1461-1467.
59. Du Pont HL, Ericsson CD, Mathewson IJ, Marani S, Knellwolf-Cousin A-L, Martinez-Sandoval FC: Zaldaride maleate, an intestinal calmodulin inhibitor in the therapy of travelers' diarrhea. Gastroenterology 1993, 104:709-715.
60. Farthing MJG: Oral rehydration therapy. Pharmacol Ther 1994,64:477-492.